<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04660383</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0458</org_study_id>
    <nct_id>NCT04660383</nct_id>
  </id_info>
  <brief_title>Intradialytic Inspiratory Muscle Training at Different Intensities and Functional Capacity</brief_title>
  <official_title>Effects of Intradialytic Inspiratory Muscle Training at Different Intensities on Diaphragm Hypertrophy and Functional Capacity in Patients Undergoing Hemodialysis: a Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the effects of Inspiratory Muscle Training (IMT) performed during hemodialysis&#xD;
      (HD) procedures in patients with end stage kidney disease (ESKD). With intervention of&#xD;
      thirty-six IMT sessions, performed three times a week, at an intensity of 50%, 30% and 10%&#xD;
      (sham) of the maximum inspiratory pressure (MIP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Chronic kidney disease (CKD), especially in its final stage (ESKD), is&#xD;
      associated with an increased risk of cardiovascular complications and mortality. Part of this&#xD;
      risk can be attributed to the fact that patients with ESKD adopt sedentary behavior.&#xD;
&#xD;
      Objectives: To investigate the effects of Inspiratory Muscle Training (IMT) performed during&#xD;
      hemodialysis (HD) procedures in patients with ESKD.&#xD;
&#xD;
      Methodology: Randomized double-blind clinical trial, controlled by sham. Location: Nephrology&#xD;
      Sector, Hospital de Clínicas de Porto Alegre (HCPA) Participants: three groups of 12 patients&#xD;
      with ESKD on HD randomized to three IMT intensities.&#xD;
&#xD;
      Intervention: Thirty-six IMT sessions, performed three times a week, at an intensity of 50%,&#xD;
      30% and 10% (sham) of the maximum inspiratory pressure (Pimax).&#xD;
&#xD;
      Main outcomes: Functional capacity, diaphragm hypertrophy, respiratory muscle strength, lung&#xD;
      volume, blood pressure and quality of life.&#xD;
&#xD;
      Statistical Analysis: Presentation of data in absolute and relative numbers, and through&#xD;
      means and standard deviations. To compare the groups, ANOVA will be used, with significance&#xD;
      less than 0.05.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2022</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Functional Capacity</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>CPET: Patients will be submitted to CPET on an exercise bike, using an incremental loading protocol according to the guidelines published by the American Thoracic Society / American College of Chest Physicians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in diaphragm hypertrophy</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Mode B ultrasound (EnVisor C, Philips, Bothell, Washington) with a 12.0 MHz ultrasound probe (L12-3, Philips) will be used for the image of the diaphragm in the apposition zone, the vertical section that rests against the lateral portion of the right rib cage, with the method described by Wait et al.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in ambulatory blood pressure measurement (ABPM)</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>ABPM is a method that allows indirect and intermittent blood pressure recordings for a period of 24 hours, while patients perform their daily life activities.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in respiratory muscle strength</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Maximal Inspiratory Measure and Maximal Expiratory Measure: will be carried out by GlobalMed® MVD300 manovacuometry equipment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in pulmonary volume</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>MIP will be measured from residual volume and MIP from total lung capacity.Lung function will be assessed by spirometry using a CardinalHealth® spirometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life assessed by KDQoL Short-Form</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <description>Assessed by Kidney Disease Quality of Life Short-Form</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <arm_group>
    <arm_group_label>IMT 50</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IMT intervention: IMT50 - 50% of the maximum inspiratory pressure (MIP), using equipment &quot;Threshold IMT®&quot; or &quot;Power Breathe®&quot;, which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMT 30</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IMT intervention: IMT30 - 30% of the maximum inspiratory pressure, using equipment &quot;Threshold IMT®&quot; or &quot;Power Breathe®&quot;, which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMT 10</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>IMT intervention: IMT10 - 10% of the maximum inspiratory pressure, using equipment &quot;Threshold IMT®&quot; or &quot;Power Breathe®&quot;, which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspiratory Muscle Training</intervention_name>
    <description>Patients will be submitted to three weekly IMT sessions in three different intensities for a period of twelve weeks, totaling 36 sessions.</description>
    <arm_group_label>IMT 10</arm_group_label>
    <arm_group_label>IMT 30</arm_group_label>
    <arm_group_label>IMT 50</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CKD patients who have been on HD for at least three months;&#xD;
&#xD;
          -  In physical conditions to perform the tests proposed by the study;&#xD;
&#xD;
          -  With stable CKD for at least 30 days (with no hospitalization);&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a recent history of arrhythmias;&#xD;
&#xD;
          -  Recent hospitalization (&lt;3 months);&#xD;
&#xD;
          -  Recent acute myocardial infarction (&lt;6 weeks);&#xD;
&#xD;
          -  HD routine less than 2X / week;&#xD;
&#xD;
          -  Muscle or respiratory changes (eg, chronic obstructive pulmonary disease (COPD));&#xD;
&#xD;
          -  Unstable angina;&#xD;
&#xD;
          -  Severe valve disease;&#xD;
&#xD;
          -  Uncontrolled hypertension;&#xD;
&#xD;
          -  Peripheral vascular disease;&#xD;
&#xD;
          -  Liver disease;&#xD;
&#xD;
          -  Hemoglobin concentration &lt;10 g / dL;&#xD;
&#xD;
          -  Problem vascular access (fistula);&#xD;
&#xD;
          -  Participation in a study with intradialytic exercise in the six months preceding this&#xD;
             study;&#xD;
&#xD;
          -  Refusal to participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Stein, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcelo Teixeira, Master</last_name>
    <phone>+55 51 992665901</phone>
    <email>msteix@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>91350-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <contact>
      <last_name>Marcelo Teixeira, Master</last_name>
      <phone>51992665901</phone>
      <email>msteix@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 1, 2020</study_first_submitted>
  <study_first_submitted_qc>December 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2020</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intradialytic training</keyword>
  <keyword>Inspiratory Muscle Training</keyword>
  <keyword>Diaphragm Hypertrophy</keyword>
  <keyword>Functional capacity</keyword>
  <keyword>End Stage Kidney Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

